Search Result "bisnorcymserine"
Prediction of Comparative Inhibition Efficiency for a Novel Natural Ligand, Galangin Against Human Brain Acetylcholinesterase, Butyrylcholinesterase and 5-Lipoxygenase: A Neuroinformatics Study
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 13 Issue: 3 Year: 2014 Page: 452-459
Author(s): Sibhghatulla Shaikh,Syed S. Ahmad,Mohammad A. Ansari,Shazi Shakil,Syed M.D. Rizvi,Shahnawaz Shakil,Shams Tabrez,Salman Akhtar,Mohammad A. Kamal
Multiple Targets for the Management of Alzheimerâs Disease
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 15 Issue: 10 Year: 2016 Page: 1279-1289
Author(s): Syed Sayeed Ahmad,Salman Akhtar,Qazi Mohammad Sajid Jamal,Syed Mohd. Danish Rizvi,Mohammad A. Kamal,M. Kalim A. Khan,Mohd. Haris Siddiqui
Selective Acetyl- and Butyrylcholinesterase Inhibitors Reduce Amyloid-β Ex Vivo Activation of Peripheral Chemo-cytokines From Alzheimers Disease Subjects: Exploring the Cholinergic Anti-inflammatory Pathway
Journal: Current Alzheimer Research
Volume: 11 Issue: 6 Year: 2014 Page: 608-622
Author(s):
Current Acetylcholinesterase-Inhibitors: A Neuroinformatics Perspective
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 13 Issue: 3 Year: 2014 Page: 391-401
Author(s): Sibhghatulla Shaikh,Anupriya Verma,Saimeen Siddiqui,Syed S. Ahmad,Syed M.D. Rizvi,Shazi Shakil,Deboshree Biswas,Divya Singh,Mohmmad H. Siddiqui,Shahnawaz Shakil,Shams Tabrez,Mohammad A. Kamal
New Pharmacological Approaches to the Cholinergic System: An Overview on Muscarinic Receptor Ligands and Cholinesterase Inhibitors
Journal: Recent Patents on CNS Drug Discovery (Discontinued)
Volume: 8 Issue: 2 Year: 2013 Page: 123-141
Author(s): Nigel H. Greig,Marcella Reale,Ada M. Tata
Enzyme Inhibitors Involved in the Treatment of Alzheimerâs Disease
Ebook: Drug Design and Discovery in Alzheimer's Disease
Volume: 1 Year: 2015
Author(s): Vageesh Revadigar,Raza Murad Ghalib,Vikneswaran Murugaiyah,Mohamed A. Embaby,Ali Jawad,Sayed Hasan Mehdi,Rokiah Hashim,Othman Sulaiman
Doi: 10.1016/B978-0-12-803959-5.50003-9
Synthesis of the Alzheimer Drug Posiphen into its Primary Metabolic Products (+)-N1-norPosiphen, (+)-N8-norPosiphen and (+)-N1, N8-bisnorPosiphen, their Inhibition of Amyloid Precursor Protein, α -Synuclein Synthesis, Interleukin-1β Release, and Cholinergic Action.
Journal: Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Volume: 12 Issue: 2 Year: 2013 Page: 117-128
Author(s): Qian-sheng Yu, Marcella Reale, Mohammad A. Kamal, Harold W. Holloway, Weiming Luo, Kumar Sambamurti, Balmiki Ray, Debomoy K. Lahiri, Jack T. Rogers, Nigel H. Greig
Different Approaches in the Treatment of Alzheimers Disease: Comprehensive Insight
Ebook: Frontiers in Clinical Drug Research - Alzheimer Disorders
Volume: 1 Year: 2013
Author(s): Zaciragic Asija
Doi: 10.2174/9781608057221113010007
Alzheimers Disease: Emerging Trends in Small Molecule Therapies
Journal: Current Medicinal Chemistry
Volume: 18 Issue: 2 Year: 2011 Page: 4299-4320
Author(s): T. Mohamed, P. P.N. Rao